We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

40 hedge funds and large institutions have $65.3M invested in Genocea Biosciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $388K | Put options by funds: $140K

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

13% less funds holding

Funds holding: 46 → 40 (-6)

18% less capital invested

Capital invested by funds: $79.4M → $65.3M (-$14.1M)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Holders
40
Holders Change
-6
Holders Change %
-13.04%
% of All Funds
0.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
2
Increased
12
Reduced
8
Closed
8
Calls
$388K
Puts
$140K
Net Calls
+$248K
Net Calls Change
-$395K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$301K
2
CC
Commodore Capital
New York
+$296K
3
Millennium Management
Millennium Management
New York
+$180K
4
Group One Trading
Group One Trading
Illinois
+$82.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$48.5K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$208K
2
Two Sigma Investments
Two Sigma Investments
New York
-$190K
3
DC
Diametric Capital
Massachusetts
-$164K
4
PCM
Prelude Capital Management
New York
-$102K
5
UOC
UBS O'Connor
Illinois
-$45K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$19.9M – – –
ACA
2
Avoro Capital Advisors
New York
$9.76M – – –
BI
3
BVF Inc
California
$7.7M – – –
CC
4
Commodore Capital
New York
$5.91M +$296K +150,309 +5%
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$5.09M +$301K +152,974 +6%
KCM
6
Kingdon Capital Management
New York
$3.79M – – –
Citadel Advisors
7
Citadel Advisors
Florida
$3.56M -$36.2K -18,410 -1%
Vanguard Group
8
Vanguard Group
Pennsylvania
$3M +$48.5K +24,638 +2%
BC
9
Boxer Capital
California
$2.18M – – –
Millennium Management
10
Millennium Management
New York
$725K +$180K +91,304 +32%
AICPI
11
ABG Innovation Capital Partners III
Hong Kong
$720K – – –
HighTower Advisors
12
HighTower Advisors
Illinois
$408K -$20 -10 -0%
PVMCV
13
Polaris Venture Management Co V
Massachusetts
$379K – – –
IC
14
Ikarian Capital
Texas
$377K -$6.25K -3,179 -2%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$357K +$12.2K +6,228 +3%
BlackRock
16
BlackRock
New York
$347K +$3.97K +2,019 +1%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$274K -$208K -106,000 -43%
Group One Trading
18
Group One Trading
Illinois
$118K +$82.5K +41,939 +213%
Two Sigma Investments
19
Two Sigma Investments
New York
$111K -$190K -96,611 -63%
Bank of America
20
Bank of America
North Carolina
$110K +$348 +177 +0.3%
Northern Trust
21
Northern Trust
Illinois
$108K +$32.6K +16,587 +42%
Commonwealth Equity Services
22
Commonwealth Equity Services
Massachusetts
$41K +$1.38K +700 +3%
BFM
23
Boothbay Fund Management
New York
$38K -$6.25K -3,179 -14%
State Street
24
State Street
Massachusetts
$38K – – –
Bank of New York Mellon
25
Bank of New York Mellon
New York
$31K – – –
1
2

GNCA Hedge Fund Activity: Q3 2021 in Review

40 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q3 2021, worth a combined $65.3M — down 18% from $79.4M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of GNCA and 2 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 12 added.

The largest buyer was Point72 Asset Management, adding an estimated $301K. The largest seller was Two Sigma Advisers, cutting an estimated $208K.

  • 40 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q3 2021, down from 46 in Q2 2021.
  • Funds reported $65.3M of Genocea Biosciences, Inc. stock for Q3 2021, down 18% quarter-over-quarter.
  • 2 funds opened new Genocea Biosciences, Inc. positions in Q3 2021 and 8 closed out, a net change of -6 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q3 2021 was Point72 Asset Management, an estimated $301K added.
  • The largest Genocea Biosciences, Inc. seller in Q3 2021 was Two Sigma Advisers, an estimated $208K sold.

Based on aggregated 13F filings for Q3 2021.